相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects
M. S. Elburki et al.
JOURNAL OF PERIODONTAL RESEARCH (2017)
The Essential Medicinal Chemistry of Curcumin
Kathryn M. Nelson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Stress-induced dynamic regulation of mitochondrial STAT3 and its association with cyclophilin D reduce mitochondrial ROS production
Jeremy A. Meier et al.
SCIENCE SIGNALING (2017)
Stress-induced dynamic regulation of mitochondrial STAT3 and its association with cyclophilin D reduce mitochondrial ROS production
Jeremy A. Meier et al.
SCIENCE SIGNALING (2017)
Mitochondrial Stat3, the Need for Design Thinking
Rui Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)
Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis
Carlos J. Diaz Osterman et al.
PANCREAS (2016)
DIFFERENTIAL SUSCEPTIBILITY OF HUMAN SP-B GENETIC VARIANTS ON LUNG INJURY CAUSED BY BACTERIAL PNEUMONIA AND THE EFFECT OF A CHEMICALLY MODIFIED CURCUMIN
Yongan Xu et al.
SHOCK (2016)
A Novel Chemically Modified Curcumin Normalizes Wound-Healing in Rats with Experimentally Induced Type I Diabetes: Initial Studies
Yazhou Zhang et al.
JOURNAL OF DIABETES RESEARCH (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Synthesis, in vitro, and in vivo evaluation of novel functionalized quaternary ammonium curcuminoids as potential anti-cancer agents
Lucas N. Solano et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells
Prashant Kesharwani et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients With BRAFV600-Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor
Douglas B. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations
Muna S. Elburki et al.
MEDIATORS OF INFLAMMATION (2014)
Roles for KRAS in Pancreatic Tumor Development and Progression
Marina Pasca di Magliano et al.
GASTROENTEROLOGY (2013)
Small molecule inhibition of the KRAS-PDEδ interaction impairs oncogenic KRAS signalling
Gunther Zimmermann et al.
NATURE (2013)
Prostate Cancer Stem Cell-Targeted Efficacy of a New-Generation Taxoid, SBT-1214 and Novel Polyenolic Zinc-Binding Curcuminoid, CMC2.24
Galina I. Botchkina et al.
PLOS ONE (2013)
The MEK-ERK Pathway Is Necessary for Serine Phosphorylation of Mitochondrial STAT3 and Ras-Mediated Transformation
Daniel J. Gough et al.
PLOS ONE (2013)
A Novel Ras Inhibitor (MDC-1016) Reduces Human Pancreatic Tumor Growth in Mice
Gerardo G. Mackenzie et al.
NEOPLASIA (2013)
Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation
Qi Sun et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
Design, Synthesis and Biological Activity of New Polyenolic Inhibitors of Matrix Metalloproteinases: A Focus on Chemically-Modified Curcumins
Yu Zhang et al.
CURRENT MEDICINAL CHEMISTRY (2012)
pKa, Zinc- and Serum Albumin-Binding of Curcumin and Two Novel Biologically- Active Chemically-Modified Curcumins
Yu Zhang et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
Meredith A. Collins et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Constitutive K-RasG12D Activation of ERK2 Specifically Regulates 3D Invasion of Human Pancreatic Cancer Cells via MMP-1
Gregory P. Botta et al.
MOLECULAR CANCER RESEARCH (2012)
Developments in metastatic pancreatic cancer: Is gemcitabine still the standard?
Jie-Er Ying et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma
Eric A. Collisson et al.
CANCER DISCOVERY (2012)
Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression
Akihisa Fukuda et al.
CANCER CELL (2011)
Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
Marina Lesina et al.
CANCER CELL (2011)
Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice
Gerardo G. Mackenzie et al.
CANCER PREVENTION RESEARCH (2011)
STAT3 Plays a Critical Role in KRAS-Induced Pancreatic Tumorigenesis
Ryan B. Corcoran et al.
CANCER RESEARCH (2011)
Inhibition of Ras for cancer treatment: the search continues
Antonio T. Baines et al.
FUTURE MEDICINAL CHEMISTRY (2011)
Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy
Murielle Mimeault et al.
CHINESE MEDICINE (2011)
Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect
Wenping Zhao et al.
CARCINOGENESIS (2009)
New Derivatives of Farnesylthiosalicylic Acid (Salirasib) for Cancer Treatment: Farnesylthiosalicylamide Inhibits Tumor Growth in Nude Mice Models
Liat Goldberg et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
Daniel J. Gough et al.
SCIENCE (2009)
Function of Mitochondrial Stat3 in Cellular Respiration
Joanna Wegrzyn et al.
SCIENCE (2009)
Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-κB and STAT3 pathways in Hodgkin's lymphoma cells
Gerardo G. Mackenzie et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice
Roni Haklai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB-regulated gene products
Ajaikumar B. Kunnumakkara et al.
CANCER RESEARCH (2007)
An in vivo platform for translational drug development in pancreatic cancer
Belen Rubio-Viqueira et al.
CLINICAL CANCER RESEARCH (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Pharmacologic inhibition of RAF→MEK→ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1
S Gysin et al.
CANCER RESEARCH (2005)
分享论文
